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In reply
We have read with interest the observation by Marais
and Graham on our recent article.1 While not
apparent in the abstract of our article, it is clear in
the methods and fully acknowledged in the discus-
sion, that our definition of ‘symptomatic’ was stricter
than the current World Health Organization (WHO)
definition.2 In our study a combination of a more
restrictive symptom definition and tuberculin skin
test (TST) positivity led to 24% of the contacts
requiring further investigation, compared to 36% in
the Indonesian study quoted by Marais et al.,3 which
used the ‘any symptom’ criteria. With active 3-
monthly follow-up for a year, we identified only
three further clinically diagnosed cases of tuberculosis
(TB) in the 3000 contacts.
A key question is whether we found TB in any of
those individuals who had no symptoms at all, who
would not have been investigated using the WHO
definition. We have now further reviewed the set of
children we had defined as not meeting the
symptom criteria in our study: of the 27 children
diagnosed with TB in this group, 19 had no
symptoms at all and were evaluated in the clinic
purely on the basis of their positive TST results.
Five of these had bacteriologically confirmed TB.
Our study is not alone in this regard. In a similar
study by Beyers et al. using the WHO definition,
seven of nine under-5 child contacts diagnosed with
culture-confirmed TB were asymptomatic at the
time of screening.4
In the study from Indonesia referred to by Marais
and Graham, we note that all 21 TB cases identified
in those aged under 5 years met more restrictive
symptom criteria,3 such as were used in our study. In
contrast, no TB disease was identified in the other 72
children with ‘any symptoms’, who therefore had a
prevalence rate of TB that was not higher than among
those with no symptoms at all.
We agree that TST testing is not feasible in most
high-burden settings, and that it is best to wait for
those children with ‘any symptoms’ to become
asymptomatic and be sure that they are not develop-
ing TB disease, before starting them on preventive
treatment. The priority must remain to identify all
children with TB disease as early as possible and to
give preventive treatment to the remaining children
under 5.
With contact tracing so poorly implemented at
present, we believe it is important to provide national
tuberculosis programmes with possible options for
contact tracing within the context of constrained
resources. As fewer children need to be further
investigated using a more restrictive symptom-based
approach combined with TST testing, and a higher
proportion of TB cases may be picked up, some
programmes with the capacity to perform TST may
prefer this approach.
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Use of inhaled corticosteroids for obstructive
lung disease following anti-tuberculosis
treatment
In 2016, we advocated for attention to be paid to
long-term respiratory dysfunction in patients who
had been diagnosed with tuberculosis and successful-
ly treated, suggesting that such patients should be
assessed and managed for chronic obstructive and
chronic restrictive lung disease if these were to be
